To accomplish this, we stained normal and breast disease tissues in a TMA that included non-malignant fibroadenomas and hyperplasia, malignant mostly carcinomas, inflammation, and metastatic breast cancer tissues with antibodies against AnxA6, GRF2, SOS1 and Ki67 (Fig 2A). This evidence concerns the gene ANXA6 and Fibroadenoma.